[Telemonitoring of patients with chronic respiratory failure in France].

La télésurveillance du patient insuffisant respiratoire chronique en France : l’opportunité d’organiser une prise en charge efficiente.
Chronic respiratory failure Insuffisance respiratoire chronique Non-invasive ventilation Oxygen therapy Oxygénothérapie Telemonitoring Télésurveillance Ventilation non invasive

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 07 10 2022
accepted: 12 05 2023
medline: 11 9 2023
pubmed: 12 6 2023
entrez: 11 6 2023
Statut: ppublish

Résumé

The year 2023 is marked by the officialization in French law of medical telemonitoring. Adult patients suffering from severe chronic respiratory failure (CRF) and being treated non-invasive ventilation (NIV) and/or oxygen therapy in a home setting are eligible for telemonitoring, of which the costs are to be covered by French health insurance. Telemonitoring allows a medical professional to remotely interpret the data necessary for follow-up and, if necessary, to make decisions regarding management of a given patient. Its objectives are, at the very least, to stabilize the disease through appropriate monitoring, to improve efficiency and quality of care, and to improve that patient's quality of life. The objective of this synthesis is to review the current state of remote monitoring of CRF patients by identifying, through a narrative analysis of the literature, its current benefits and limitations, and to compare present-day telemonitoring with the guidelines of the official French health authority (Haute Autorité de santé) for its nationwide application.

Identifiants

pubmed: 37302904
pii: S0761-8425(23)00172-9
doi: 10.1016/j.rmr.2023.05.002
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

623-629

Informations de copyright

Copyright © 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

J-C Borel (JC)

Département de recherche et développement AGIR à domicile, 36, boulevard du Vieux Chêne, 38240 Meylan, France; Laboratoire HP2 U1300, domaine de la Merci, 38700 La Tronche, France. Electronic address: j.borel@agiradom.com.

F Bughin (F)

Inserm, PhyMedExp, CNRS, CHU de Montpellier, université de Montpellier, Montpellier, France; Clinique du Millénaire, Montpellier, France.

J Texereau (J)

Air Liquide Healthcare, VitalAire, Bagneux, France; Physiologie respiratoire, hôpital Cochin, AP-HP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH